Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Latte Dosage Trial of caffeine citrate for intermittent hypoxaemia in late preterm infants
ACTRN12618001745235Phase 2Completed
- Sponsor
- The University of Auckland
- Start
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of caffeine in Intermittent hypoxaemia (IH) (5 arms), sponsored by The University of Auckland. Primary endpoint: Frequency of intermittent hypoxaemia. Started Feb 2019; status: completed.
02
Drugs
caffeine
03
Conditions
Intermittent hypoxaemia (IH)
Beyond the preview
Go deeper on ACTRN12618001745235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618001745235.